Absci Corp (ABSI)
5.01
-0.20
(-3.84%)
USD |
NASDAQ |
May 07, 14:09
Absci Cash from Operations (TTM): -64.64M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -64.64M |
| September 30, 2023 | -68.28M |
| June 30, 2023 | -76.96M |
| March 31, 2023 | -80.31M |
| December 31, 2022 | -81.34M |
| September 30, 2022 | -79.85M |
| June 30, 2022 | -82.55M |
| Date | Value |
|---|---|
| March 31, 2022 | -74.46M |
| December 31, 2021 | -60.60M |
| September 30, 2021 | -46.04M |
| June 30, 2021 | -27.00M |
| March 31, 2021 | -15.83M |
| December 31, 2020 | -10.97M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-82.55M
Minimum
Jun 2022
-10.97M
Maximum
Dec 2020
-59.14M
Average
-68.28M
Median
Sep 2023
Cash from Operations (TTM) Benchmarks
| Amgen Inc | 8.096B |
| Creative Medical Technology Holdings Inc | -8.028M |
| CytomX Therapeutics Inc | -56.04M |
| HOOKIPA Pharma Inc | -57.52M |
| Recursion Pharmaceuticals Inc | -287.78M |